FLGT — Fulgent Genetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1674930 ·
Last close
$22.20
Market Cap
$610.84M
52W High
$31.04
52W Low
$13.46
ADV30
299,183
Next earnings
2026-11-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 85,389,000 | 25,679,000 | -33,901,000 | -29,530,000 | 1,089,223,000 | 26,305,000 | 93,237,000 |
| Mar 2026 | 71,138,000 | 21,490,000 | -34,622,000 | -24,826,000 | 1,156,369,000 | 23,399,000 | 112,215,000 |
| Dec 2025 | 83,336,000 | 32,582,000 | -36,238,000 | -23,418,000 | 1,213,525,000 | 50,193,000 | 106,810,000 |
| Sep 2025 | 84,069,000 | 35,512,000 | -15,350,000 | -6,608,000 | 1,214,563,000 | 117,641,000 | 93,806,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,697,000
Investing CF
$91,978,000
Financing CF
$-70,037,000
CapEx
$-20,090,000
Dividends Paid
—
Buybacks
$-69,221,000
EPS Diluted TTM
$-2.82
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$475,598,000
Inventory
$11,666,000
Receivables
$70,527,000
ST Investments
$230,727,000
EBIT TTM
$-92,331,000
Pretax Income TTM
$-92,451,000
Interest Exp TTM
$120,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$323,932,000
EBITDA
$-89,461,000
Free Cash Flow
$-90,904,376
Enterprise Value
$309,625,728
Total Cash
$257,032,000
Total Debt
$9,603,000
Shares Out
27,515,293
Trailing EPS
$-2.83
Book Value
$36.40
ROE
-8.1%
ROA
-6.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 322,671,000 | -91,096,000 | -60,513,000 | 1,213,525,000 | 106,810,000 | 1,111,989,000 | -101,638,000 |
| Dec 2024 | 283,470,000 | -73,918,000 | -42,708,000 | 1,219,964,000 | 90,805,000 | 1,133,228,000 | 21,060,000 |
| Dec 2023 | 289,213,000 | -75,295,000 | -167,825,000 | 1,235,328,000 | 102,042,000 | 1,136,101,000 | 27,003,000 |
| Dec 2022 | 618,968,000 | 181,502,000 | 143,403,000 | 1,386,053,000 | 116,178,000 | 1,266,685,000 | 253,520,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.38
Max Pain — expiry 2027-01-15
max pain strike: $17.50 · spot: $21.93 · call oi: 1,566 · put oi: 10Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SBC | SBC Medical Group Holdings Inc | $503.95M | $4.90 | — |
| AHCO | AdaptHealth Corp. | $752.43M | $5.64 | — |
| SRTA | Strata Critical Medical, Inc. | $471.53M | $5.33 | — |
| MCTA | Charming Medical Ltd | $445.55M | $29.35 | — |
| DFPH | Starling Oncology, Inc. | $436.37M | $2.01 | — |
News headlines (Yahoo Finance, 1h cache)
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript
2026-08-08 02:14 · Yahoo
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets
2026-08-06 06:09 · Yahoo
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ...
2026-07-31 05:03 · Yahoo
Fulgent Genetics Q2 Earnings Call Highlights
2026-07-30 23:04 · Yahoo
Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue Estimates
2026-07-30 22:00 · Yahoo
Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions
2026-06-25 06:07 · Yahoo
How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments
2026-06-07 14:13 · Yahoo
Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...
2026-05-02 07:01 · Yahoo
Fulgent Genetics Q1 Earnings Call Highlights
2026-05-01 13:52 · Yahoo
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
2026-05-01 12:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.